Eribulin in Advanced Solitary Fibrous Tumor
Clinical trial NCT03840772 · COMPLETED
Trial details
- NCT number
- NCT03840772
- Sponsor
- Italian Sarcoma Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-17
- Primary completion
- 2024-09-18
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.